Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows a new revision tag, 'Revision: v3.6.5', replacing the previous version tag. This indicates a minor platform/version update for the page, with no changes to study details or user-facing content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated to v3.6.4, indicating a system upgrade or patch was applied to the page. This change does not modify study content or user-facing information.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's documentation or front-end labels rather than a substantive content change.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous Revision: v3.6.0. It appears to be a frontend/system version update rather than a change to trial details or participant information.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now indicates that recruitment is closed, and introduces or updates several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting change to the Intervention/Treatment label; a new Revision: v3.6.0 replaces the previous version.SummaryDifference0.5%

- Check84 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a newer software revision of the ClinicalTrials.gov page.SummaryDifference0.1%

Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.